Search research articles
Contact Us
Filters
Showing results (71-80 of 106) with videos related to
Page
of 11
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study
Gérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2016
Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease
Marwan N Sabbagh, Barbara Schäuble, Keshav Anand, et al.
The American Journal of Psychiatry
|
July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder
Aybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Annals of Clinical and Translational Neurology
|
March 11, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Journal of Parkinson'S Disease
|
September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)
Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study
John Seibyl, Ana M Catafau, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Movement Disorders Clinical Practice
|
June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Journal of Parkinson'S Disease
|
September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 106) with videos related to
Sort By:
Page
of 11
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 13, 2021
Toward a Universal Readout for <sup>18</sup>F-Labeled Amyloid Tracers: The CAPTAINs Study
Gérard N Bischof, Peter Bartenstein, Henryk Barthel, et al.
Journal of Alzheimer'S Disease : JAD
|
December 17, 2016
Histopathology and Florbetaben PET in Patients Incorrectly Diagnosed with Alzheimer's Disease
Marwan N Sabbagh, Barbara Schäuble, Keshav Anand, et al.
The American Journal of Psychiatry
|
July 10, 2012
Persistent β2*-nicotinic acetylcholinergic receptor dysfunction in major depressive disorder
Aybala Saricicek, Irina Esterlis, Kathleen H Maloney, et al.
Annals of Clinical and Translational Neurology
|
March 11, 2026
Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
Paulina Gonzalez-Latapi, Caroline Gochanour, Seung Ho Choi, et al.
Journal of Parkinson'S Disease
|
September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)
Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 30, 2016
Impact of Training Method on the Robustness of the Visual Assessment of 18F-Florbetaben PET Scans: Results from a Phase-3 Study
John Seibyl, Ana M Catafau, Henryk Barthel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
July 31, 2019
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease
Brit Mollenhauer, Chelsea J Caspell-Garcia, Christopher S Coffey, et al.
Movement Disorders Clinical Practice
|
June 19, 2023
Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study
Daniel Weintraub, Marina Picillo, Hyunkeun Ryan Cho, et al.
Journal of Parkinson'S Disease
|
September 17, 2019
The Qualification of an Enrichment Biomarker for Clinical Trials Targeting Early Stages of Parkinson's Disease
Diane Stephenson, Derek Hill, Jesse M Cedarbaum, et al.
Page
of 11